MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
7.70
-0.32 (-3.99%)
Oct 16, 2026, 4:00 PM EDT - Market closed
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $427.93 million as of October 16, 2026. It is the 15,791st most valuable company in the world and the 2,849th biggest in the United States.
Market Cap
427.93M
Enterprise Value
125.20M
1-Year Change
n/a
Global Rank
Country Rank
#2,849 United States
Category
ChartMarket Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has decreased from $704.29M to $427.93M, a decrease of -39.24%. That is a compound annual growth rate of -40.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 427.93M | -44.18% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arvinas | 468.17M |
| Allogene Therapeutics | 462.96M |
| Altimmune | 459.06M |
| Autolus Therapeutics | 457.80M |
| Oculis Holding AG | 456.82M |
| Eupraxia Pharmaceuticals | 447.05M |
| Ovid Therapeutics | 441.37M |
| ProKidney | 439.88M |